cognitive cybersecurity intelligence
L.P., a venture capital firm dedicated to early-stage biomedical innovation, has closed its first venture fund, ABV1, with $135 million in funding from new and existing institutional investors.
Avalon BioVentures emerged from Avalon Ventures’ shared life-science/high-tech…
Source: www.labiotech.eu – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Threat Actors Advertising Anivia Stealer Malware on Dark Web bypassing UAC Controls CybersecurityNews
Halloween scams spike as 63% of festive spam found malicious SecurityBrief Australia
‘Dante’ Malware reportedly targeted Chrome users through zero-day exploit Android Headlines
YouTube Ghost Network Uses Scary Tactics, Targets Users Dark Reading | Security
